Internal Medicine · Flushing, NY
NPI
1518236181
Since 2011
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
4235 Main St, Ste 3m
Flushing, NY, 11355
Phone (347) 341-0365
Groups this clinician bills Medicare through
Medicare paid, 2024
$239K
3,962 services
Medicare patients, 2024
441
Average age 81
Drug cost, 2024
$9.1M
56,330 prescriptions
Company payments, 2025
$4,613
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wu Tan was code 99307 (snf e&m), 1,523 times for 214 patients. In total Wu Tan billed 3,962 services in 26 codes, and Medicare paid $239K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99307 SNF E&M | Facility | 1,523 | 214 | $29.77 | $45K |
| 99309 SNF E&M | Facility | 1,042 | 255 | $92.89 | $97K |
| 99490 Chronic, Principal, and Transitional Care Management | Facility | 561 | 201 | $42.33 | $24K |
| 99213 Office E&M - Established | Office | 192 | 56 | $74.00 | $14K |
| 99306 SNF E&M | Facility | 156 | 135 | $157.26 | $25K |
| 99316 SNF E&M | Facility | 150 | 118 | $112.12 | $17K |
| 99308 SNF E&M | Facility | 140 | 118 | $61.79 | $8,651 |
| 96372 Injection Administration | Office | 59 | 13 | $11.77 | $694 |
| 93000 Electrocardiogram | Office | 19 | 15 | $10.90 | $207 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 15 | $32.91 | $527 |
| 90661 Vaccine Product | Office | 13 | 13 | $36.11 | $469 |
By year: 2022 $148K for 2,327 services; 2023 $198K for 3,110 services; 2024 $239K for 3,962 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wu Tan prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,024 prescriptions and refills. In total Wu Tan wrote 56,330 Medicare prescriptions that cost $9.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,024 | 3,326 | 407 | $23K |
| Amlodipine Besylate Generic | 2,288 | 2,647 | 278 | $13K |
| Losartan Potassium Generic | 2,174 | 2,626 | 292 | $13K |
| Tamsulosin Hcl Generic | 1,617 | 1,846 | 222 | $15K |
| Metoprolol Succinate Generic | 1,482 | 1,690 | 211 | $14K |
| Rosuvastatin Calcium Generic | 1,199 | 1,496 | 150 | $6,955 |
| Donepezil Hcl Generic | 1,140 | 1,238 | 186 | $7,254 |
| Famotidine Generic | 989 | 1,073 | 194 | $14K |
| Farxiga Dapagliflozin Propanediol | 925 | 1,105 | 144 | $582K |
| Metformin Hcl Er Metformin Hcl | 921 | 1,094 | 146 | $3,755 |
| Diclofenac Epolamine Generic | 855 | 938 | 172 | $614K |
| Finasteride Generic | 832 | 956 | 122 | $5,042 |
| Linzess Linaclotide | 743 | 798 | 144 | $417K |
| Jardiance Empagliflozin | 734 | 839 | 118 | $461K |
| Metformin Hcl Generic | 733 | 814 | 99 | $4,754 |
Brand drugs: 11,973 claims; generic drugs: 43,843 claims; opioid claims: 196.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wu Tan $4,613 ($4,613 in general payments such as food, travel and fees) from 26 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $440.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $440 |
| Esperion Therapeutics, Inc. ESPR | 17 | $391 |
| Abbvie Inc. ABBV | 16 | $328 |
| Genzyme Corporation SNY | 10 | $317 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 15 | $316 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $293 |
| Merck Sharp & Dohme LLC MRK | 11 | $275 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 15 | $244 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $237 |
| GlaxoSmithKline, LLC. GSK | 11 | $229 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.